Sign in
HS

HEALTHCARE SERVICES GROUP INC (HCSG)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 delivered headline beats with revenue $464.3M (+8.5% YoY; +1.3% QoQ) and diluted EPS $0.59; EPS was boosted by a $0.361 per-share benefit primarily from Employee Retention Credit (ERC) items, partially offset by the Genesis charge, while revenue modestly topped consensus . Versus S&P Global consensus, EPS materially beat ($0.59 vs $0.20*) and revenue was slightly ahead ($464.3M vs $460.4M*) .
  • Mix/quality: Cost of services (79.2% of sales) included a 6.8% benefit tied to ERC (net of Genesis charge), and other income included $5.3M of ERC interest; operating cash flow of $71.3M ($87.1M ex-payroll accrual) included $31.8M from ERC .
  • Management cited sustained new-client wins and 90%+ retention as drivers of a sixth consecutive sequential revenue increase; Q4 revenue estimated at $460–$470M, consistent with ongoing momentum .
  • Capital allocation: $27.3M of buybacks in Q3 (YTD $42.0M) under the $50M plan announced in July; cash and marketable securities ended Q3 at $207.5M with an undrawn $500M revolver (LCs only) .
  • Watch items: outsized EPS beat from ERC benefits, ongoing Genesis restructuring process and timing, and August disclosures and legal actions around a 2024 data breach affecting ~624K individuals .

What Went Well and What Went Wrong

What Went Well

  • Momentum and execution: “We delivered strong third quarter results – marked by year-over-year and sequential increases in revenue, earnings, and cash flow” with positive momentum into Q4 .
  • Organic growth durability: New client wins and high retention (90%+) drove topline; Q3 marked the sixth consecutive sequential revenue increase, “our highest rate of growth since Q1 2018” .
  • Liquidity and buybacks: Cash and marketable securities $207.5M; undrawn revolver; repurchased $27.3M of stock in Q3 under the $50M 12‑month plan .

What Went Wrong

  • Earnings quality/one‑offs: Reported EPS includes a $0.361 per-share benefit primarily from ERC ($0.392) offset by the Genesis charge ($0.033), inflating headline profitability; cost of services also had a 6.8% ERC-related benefit .
  • Genesis restructuring overhang: While operations and payments remain normal course, the process runs through bid deadlines/sale hearing and likely closing into late spring/summer, creating timeline uncertainty .
  • Cyber/data breach exposure: August releases indicate cybercriminal access (Sept 27–Oct 3, 2024) impacting ~624,496 individuals, spawning investigations/class-action solicitations—creating potential legal and reputational risk .

Financial Results

Income statement and cash flow (prior year, prior quarter, current)

MetricQ3 2024Q2 2025Q3 2025
Revenue ($MM)$428.149 $458.491 $464.338
Diluted EPS ($)$0.19 ($0.44) $0.59
Cost of services ($MM)$364.730 $455.533 $367.933
SG&A ($MM)$46.888 $49.163 $50.541
Other income, net ($MM)$2.277 $4.317 $11.444
Adjusted EBITDA ($MM)$24.806 ($36.322) $56.393
Adjusted EBITDA Margin (%)5.8% (7.9%) 12.1%
Cash flow from operations ($MM)$4.312 $28.787 $71.293
CFO ex payroll accrual ($MM)$18.994 $8.531 $87.092

Notes:

  • Cost of services in Q3 included a 6.8% benefit (net) primarily from ERC; other income included $5.3M ERC interest; CFO included $31.8M ERC benefit .

Segment performance

Segment MetricQ1 2025Q2 2025Q3 2025
Environmental Services Revenue ($MM)$196.3 $205.8 $211.8
Environmental Services Segment Margin (%)10.8% 0.8% (incl. Genesis charge) 10.7% (incl. ~$1.2M Genesis charge)
Dietary Services Revenue ($MM)$251.3 $252.7 $252.5
Dietary Services Segment Margin (%)7.6% (10.1%) (incl. Genesis charge) 5.1% (incl. ~$1.5M Genesis charge)

KPIs and balance sheet

KPIQ3 2025
Cash + marketable securities ($MM)$207.5
Q4 revenue outlook ($MM)$460–$470 (management estimate)
Share repurchases in Q3 ($MM)$27.3
ERC in cost of services (benefit)$34.2M; net CoS benefit 6.8% after Genesis
ERC interest in other income$5.3M
CFO ERC benefit$31.8M
Deferred ERC liability (BS)$12.3M (related to Q3’21 period)
Client retention~90%+ (management commentary)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueQ4 2025Not previously provided$460–$470M (estimate) New
Cost of services (target)2H 2025 / near-term“86% range” “86% range” (goal) Maintained
SG&A as % of revenueNear-term9.5%–10.5% 9.5%–10.5% (LT 8.5%–9.5%) Maintained
Cash flow from ops (ex payroll accrual)FY 2025$70–$85M (raised in Q2) No update in Q3 (implicitly maintained) Maintained
Genesis restructuring chargeQ3 2025~($0.04) EPS expected Actual impact ~$0.033 EPS Slightly better than expected

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2, Q1)Current Period (Q3)Trend
Regulatory/policy (ABBA/OBBBA)Q2: Constructive on OBBBA (10-yr moratorium on minimum staffing, exemption from provider tax cuts, $50B rural investment) Q3: Headlines noted; foundational benefits remain intact; expect prioritization of vulnerable populations and rationalized regulations Constructively positive, policy supportive
Labor/StaffingQ2: Industry hiring improving; occupancy trends positive Q3: Wage growth stabilizing; applications at record levels; no labor headwind to growth Improving availability supports census and growth
Growth pipeline & retentionQ1: Reiterated mid-single-digit growth; strong revenue/CFO start Q3: 6th consecutive sequential revenue increase; 90%+ retention; EVS-to-Dining cross-sell still <~50% penetrated Broad-based momentum; cross-sell runway
Genesis restructuringQ2: $61.2M non-cash charge; small Q3 follow-on expected Q3: Normal ops/payments; DIP and bid procedures approved; potential sale close late spring/summer Process visibility improving, timing risk remains
Cybersecurity/data breachNot discussed in Q1/Q2 company materialsAug disclosures: ~624,496 affected; class-action investigations initiated Emerging legal/reputational risk

Management Commentary

  • “New client wins and high retention rates drove our topline growth, and our field-based teams' operational excellence led to quality service outcomes and consistent margins.” – CEO Ted Wahl .
  • “The third quarter was our sixth consecutive sequential revenue increase and really our highest rate of growth since Q1 of 2018.” – CEO Ted Wahl .
  • “We estimate Q4 revenue in the range of $460 to $470 million.” – Management .
  • “We ended the third quarter with cash and marketable securities of $207.5 million... the company received $31.8 million in ERC receipts [in Q3]... Other income includes $5.3 million of interest income related to the ERC.” – CFO Vikas Singh .

Q&A Highlights

  • Pipeline and cross-sell: Majority of sequential topline increase driven by new wins; pipeline split fairly evenly between EVS and Dining; dining revenue ≈2x EVS on same-store basis; dining penetration still ~50% within EVS base .
  • Labor conditions: Wage growth has stabilized; applications at record levels; management sees no labor availability constraint on growth .
  • Genesis process: DIP and bid procedures approved; early Nov bid deadline, mid-Nov sale hearing; potential close late spring/summer; operations/payments remain normal course at facility level .
  • “Campuses” (education adjacency): Less than 5% of revenue but growing; top M&A target area; synergies emerging between EVS and dining brands .

Estimates Context

MetricConsensus (Q3 2025)*Actual (Q3 2025)Surprise
Revenue ($MM)$460.358*$464.338 +$3.98
Diluted EPS ($)$0.199*$0.59 +$0.39
  • EPS beat largely reflects one-time/temporary items: diluted EPS includes a $0.361 per‑share benefit primarily from ERC (incl. $0.392 ERC and ($0.033) Genesis), plus ERC boosted cost of services and other income, and operating cash flow .
  • Estimate counts: 4 for revenue and 4 for EPS (consensus breadth modest)*.

Values with asterisks retrieved from S&P Global.

Key Takeaways for Investors

  • Core growth trend remains favorable (new wins, ~90% retention, 6th straight sequential revenue increase), with Q4 revenue estimated at $460–$470M indicating continuity into year-end .
  • Headline EPS strength reflects significant ERC benefits; normalize for ERC/Genesis to assess run-rate profitability and margin trajectory as management targets cost of services in the 86% range and SG&A at 9.5%–10.5% near term .
  • Cash generation and balance sheet provide flexibility (C&M securities $207.5M; undrawn revolver); buybacks ($27.3M in Q3; $50M plan) enhance per-share metrics .
  • Monitor Genesis milestones (bid/sale timing, potential facility transitions) and any working-capital or margin implications despite normal course current operations .
  • Track cybersecurity/legal developments tied to the 2024 breach disclosures (624K affected) for potential cost and reputational impacts .
  • Medium-term thesis hinges on continued EVS-to-Dining cross-sell (sub-50% penetrated), stabilization of labor costs, and sustained industry tailwinds from demographic demand and supportive policy environment .

Appendix: Additional Details and Disclosures

  • Q3 results detail:
    • Revenue $464.3M (+8.5% YoY); Cost of services $367.9M (79.2%) incl. net 6.8% ERC benefit; SG&A $50.5M (adj. $46.8M, 10.1%); other income $11.4M (incl. $5.3M ERC interest); diluted EPS $0.59 (incl. $0.361 ERC-related benefit); CFO $71.3M ($87.1M ex-payroll accrual) incl. $31.8M ERC .
  • Share repurchase: $27.3M in Q3; YTD $42.0M; $50M plan through June 2026; 3.1M shares remain under Feb 2023 authorization .
  • Liquidity: Cash and marketable securities $207.5M; $500M undrawn credit facility (incl. $200M accordion) .
  • Segment margins: EVS 10.7% (incl. ~$1.2M Genesis charge); Dining 5.1% (incl. ~$1.5M Genesis charge) .